药品注册申请号:087499
申请类型:ANDA (仿制药申请)
申请人:WATSON LABS
申请人全名:WATSON LABORATORIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG No No AA 1982/04/20 1982/04/20 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/04/27 SUPPL-58(补充) Approval Labeling STANDARD
2020/04/27 SUPPL-55(补充) Approval Labeling STANDARD
2013/07/26 SUPPL-54(补充) Approval Labeling STANDARD
2010/04/27 SUPPL-47(补充) Approval Labeling
2010/01/25 SUPPL-43(补充) Approval Labeling
2009/01/29 SUPPL-37(补充) Approval Labeling
2001/04/25 SUPPL-23(补充) Approval Manufacturing (CMC)
2001/03/22 SUPPL-22(补充) Approval Manufacturing (CMC)
1999/09/14 SUPPL-21(补充) Approval Manufacturing (CMC)
1998/12/21 SUPPL-19(补充) Approval Manufacturing (CMC)
1998/12/21 SUPPL-18(补充) Approval Manufacturing (CMC)
1998/12/21 SUPPL-17(补充) Approval Manufacturing (CMC)
1997/06/20 SUPPL-16(补充) Approval Manufacturing (CMC)
1991/12/19 SUPPL-11(补充) Approval Manufacturing (CMC)
1991/12/19 SUPPL-10(补充) Approval Manufacturing (CMC)
1991/12/19 SUPPL-9(补充) Approval Manufacturing (CMC)
1991/12/19 SUPPL-8(补充) Approval Manufacturing (CMC)
1991/01/28 SUPPL-14(补充) Approval Manufacturing (CMC)
1990/06/29 SUPPL-12(补充) Approval Manufacturing (CMC)
1989/12/20 SUPPL-15(补充) Approval Bioequivalence
1988/10/27 SUPPL-7(补充) Approval Labeling
1988/04/01 SUPPL-6(补充) Approval Manufacturing (CMC)
1986/01/07 SUPPL-5(补充) Approval Manufacturing (CMC)
1985/07/05 SUPPL-4(补充) Approval Manufacturing (CMC)
1985/07/05 SUPPL-3(补充) Approval Manufacturing (CMC)
1984/03/29 SUPPL-2(补充) Approval Manufacturing (CMC)
1983/04/21 SUPPL-1(补充) Approval Manufacturing (CMC)
1982/04/20 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CARISOPRODOL 剂型/给药途径:TABLET;ORAL 规格:350MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011792 001 NDA SOMA CARISOPRODOL TABLET;ORAL 350MG Prescription Yes No AA Approved Prior to Jan 1, 1982 MYLAN SPECIALITY LP
087499 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 1982/04/20 WATSON LABS
081025 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 1989/04/13 WANBANG BIOPHARMS
040188 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 1997/03/07 OXFORD PHARMS
040245 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 1997/09/08 CHARTWELL RX
040576 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2005/06/07 ACCELRX LABS
040823 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2008/10/22 NOVAST LABS
040792 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2009/08/06 AUROBINDO PHARMA
203374 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2014/01/27 SCIEGEN PHARMS INC
205085 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2014/10/28 ORIENT PHARMA CO LTD
090988 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2014/10/28 NATCO
205126 002 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2015/07/08 CHARTWELL RX
207237 002 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Prescription No No AA 2020/09/21 NOSTRUM LABS INC
211789 001 ANDA CARISOPRODOL CARISOPRODOL TABLET;ORAL 350MG Discontinued No No AA 2021/10/20 ALLIED
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database